文献速递心脑血管急症重症综合管理与镇静镇痛

先前取栓不影响恶性缺血性卒中减压性半颅切除术的手术并发症率

Prior Thrombectomy Does Not Affect the Surgical Complication Rate of Decompressive Hemicraniectomy in Patients with Malignant Ischemic Stroke.
PubMed 文献 · Neurocrit Care · 2023-08-28
一句话结论回顾性队列显示,恶性大脑中动脉梗死患者取栓后再行减压性半颅切除术,手术并发症率与未取栓者无显著差异(10.2% vs 11.1%)。

该回顾性队列研究纳入103例因恶性大脑中动脉梗死接受减压性半颅切除术的连续患者,比较术前接受机械再通(取栓组,n=49)与未接受机械再通(药物组,n=54)患者的手术与功能结局。两组手术并发症率(10.2% vs 11.1%)、术后30天内翻修手术率(4.1% vs 5.6%)及功能结局(两组5个月和14个月中位改良Rankin评分均为4)均无显著差异。作者结论认为,先前机械再通及可能相关的全身溶栓不影响减压性半颅切除术后的早期手术并发症率和功能结局,既往大型随机对照试验结果在现代卒中治疗时代仍然有效。

要点

  • 取栓组与药物组手术并发症率分别为10.2%与11.1%,无显著差异。
  • 术后30天内翻修手术率取栓组4.1% vs 药物组5.6%,无显著差异。
  • 两组5个月和14个月中位改良Rankin评分均为4,功能结局无显著差异。
  • 取栓组术前全身溶栓比例63.3% vs 药物组18.5%(p<0.001),出血转化率44.9% vs 24.1%(p=0.04),术前格拉斯哥昏迷评分中位数7 vs 12(p=0.04)。
  • 作者认为,先前机械再通及可能相关的全身溶栓不影响减压性半颅切除术后的早期手术并发症率和功能结局。

适用人群与场景

  • 因恶性大脑中动脉梗死接受减压性半颅切除术的连续患者,共103例;取栓组49例,药物组54例。
  • 本研究为回顾性队列研究。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入103例因恶性大脑中动脉梗死接受减压性半颅切除术的连续患者,比较术前接受机械再通(取栓组,n=49)与未接受机械再通(药物组,n=54)患者的手术与功能结局。
  • 取栓组术前全身溶栓比例63.3% vs 药物组18.5%(p<0.001)。
  • 取栓组出血转化率44.9% vs 药物组24.1%(p=0.04)。
  • 取栓组术前格拉斯哥昏迷评分中位数7 vs 药物组12(p=0.04)。
  • 手术并发症率取栓组10.2% vs 药物组11.1%,无显著差异。
  • 术后30天内翻修手术率取栓组4.1% vs 药物组5.6%,无显著差异。
  • 功能结局:两组5个月和14个月中位改良Rankin评分均为4,无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,先前机械再通及可能相关的全身溶栓不影响减压性半颅切除术后的早期手术并发症率和功能结局。
  • 作者认为,患者特征自机械再通引入以来未发生显著变化,因此既往大型随机对照试验的结果在现代卒中治疗时代仍然有效。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Even though mechanical recanalization techniques have dramatically improved acute stroke care since the pivotal trials of decompressive hemicraniectomy for malignant courses of ischemic stroke, decompressive hemicraniectomy remains a mainstay of malignant stroke treatment. However, it is still unclear whether prior thrombectomy, which in most cases is associated with application of antiplatelets and/or anticoagulants, affects the surgical complication rate of decompressive hemicraniectomy and whether conclusions derived from prior trials of decompressive hemicraniectomy are still valid in times of modern stroke care.

METHODS: A total of 103 consecutive patients who received a decompressive hemicraniectomy for malignant middle cerebral artery infarction were evaluated in this retrospective cohort study. Surgical and functional outcomes of patients who had received mechanical recanalization before surgery (thrombectomy group, n = 49) and of patients who had not received mechanical recanalization (medical group, n = 54) were compared.

RESULTS: The baseline characteristics of the two groups did significantly differ regarding preoperative systemic thrombolysis (63.3% in the thrombectomy group vs. 18.5% in the medical group, p < 0.001), the rate of hemorrhagic transformation (44.9% vs. 24.1%, p = 0.04) and the preoperative Glasgow Coma Score (median of 7 in the thrombectomy group vs. 12 in the medical group, p = 0.04) were similar to those of prior randomized controlled trials of decompressive hemicraniectomy. There was no significant difference in the rates of surgical complications (10.2% in the thrombectomy group vs. 11.1% in the medical group), revision surgery within the first 30 days after surgery (4.1% vs. 5.6%, respectively), and functional outcome (median modified Rankin Score of 4 at 5 and 14 months in both groups) between the two groups.

CONCLUSIONS: A prior mechanical recanalization with possibly associated systemic thrombolysis does not affect the early surgical complication rate and the functional outcome after decompressive hemicraniectomy for malignant ischemic stroke. Patient characteristics have not changed significantly since the introduction of mechanical recanalization; therefore, the results from former large randomized controlled trials are still valid in the modern era of stroke care.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Walter J, Alhalabi OT, Schönenberger S, et al. Prior Thrombectomy Does Not Affect the Surgical Complication Rate of Decompressive Hemicraniectomy in Patients with Malignant Ischemic Stroke. Neurocrit Care. 2023. PMID: 37639204. doi:10.1007/s12028-023-01820-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。